Member access

4-Traders Homepage  >  Shares  >  Mercado Continuo Espanol  >  FAES Farma SA    FAE   ES0134950F36

FAES FARMA SA (FAE)

5
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Mercado Continuo Espanol
04/27/2015 04/28/2015 04/29/2015 04/30/2015 05/04/2015 Date
2.35(c) 2.335(c) 2.295(c) 2.305(c) 2.32(c) Last
153 499 200 339 248 119 328 810 263 826 Volume
-0.21% -0.64% -1.71% +0.44% +0.65% Change
More quotes
Financials (€)
Sales 2015 201 M
EBIT 2015 37,8 M
Net income 2015 27,3 M
Finance 2015 9,17 M
Yield 2015 2,60%
Sales 2016 211 M
EBIT 2016 44,5 M
Net income 2016 34,0 M
Finance 2016 41,9 M
Yield 2016 2,78%
PER 2015 19,32
PER 2016 16,34
EV / Sales 2015 2,79x
EV / Sales 2016 2,51x
Capitalization 571 M
More Financials
Company
Faes Farma SA engages in the manufacture, marketing, and research of pharmaceutical products and raw materials for pharmaceutical use. Its products are for allergies, antihypertensive, dermatological, diabetes, digestive, otorhinolaryngology, osteoarticular, respiratory, women's health, central... 
Sector
Pharmaceuticals
Calendar
07/31Earnings Release
More about the company
Surperformance© ratings of FAES Farma SA
Trading Rating : Investor Rating :
More Ratings
Latest news on FAES FARMA SA
03/02 FAES FARMA : Statement 02/27/2015 (81 k.). Faes Farma increases its net probit b..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2014 FAES FARMA : Statement 05/14/2014 (112 k.). Bilastine in Canada: signing of a li..
2013 FAES FARMA SA : Statement 07/24/2013 (24 k.). January-June results.
2012 FAES FARMA SA : Statement 13/12/2012 (20 k). Faes Farma licences bilastine for S..
2012 FAES FARMA SA : Statement 02/07/2012 (19 k). FAES FARMA S.A. informs of the appr..
2012 FAES FARMA SA : ex-dividend day for final dividend
2012 FAES FARMA SA : Statement 26/04/2012 (28 k). FAES FARMA and INVIDA (MENARINI Gro..
More news
Sector news : Pharmaceuticals - NEC
08:41p NOVO NORDISK A/S : Diabetic cycling team ready for Amgen Tour of California
05:13pDJGeneric Drugs Grab Growing Market Share in Mexico--Update
05:11pDJGeneric Drugs Grab Market Share in Mexico
More sector news : Pharmaceuticals - NEC


Comments 
Advertisement
Chart FAES FARMA SA
Duration : Period :
FAES Farma SA Technical Analysis Chart | FAE | ES0134950F36 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF